BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
25.39
+0.38 (1.52%)
Nov 21, 2024, 4:00 PM EST - Market closed
BioLife Solutions Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 146.96 | 143.27 | 161.76 | 119.16 | 48.09 | 27.37 | Upgrade
|
| Revenue Growth (YoY) | 16.40% | -11.43% | 35.75% | 147.79% | 75.69% | 38.64% | Upgrade
|
| Cost of Revenue | 91.81 | 96.52 | 107.69 | 80.98 | 20.24 | 8.47 | Upgrade
|
| Gross Profit | 55.15 | 46.75 | 54.07 | 38.18 | 27.85 | 18.9 | Upgrade
|
| Selling, General & Admin | 74.36 | 80.31 | 69.24 | 47.67 | 21.69 | 13.59 | Upgrade
|
| Research & Development | 14.85 | 18.8 | 14.8 | 11.82 | 6.72 | 3.17 | Upgrade
|
| Operating Expenses | 92.99 | 104.29 | 93.74 | 67.7 | 31.44 | 17.84 | Upgrade
|
| Operating Income | -37.85 | -57.53 | -39.66 | -29.52 | -3.59 | 1.06 | Upgrade
|
| Interest Expense | -1.39 | -1.81 | -0.69 | -0.49 | - | - | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.04 | 0.5 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -0.74 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.68 | 1.26 | 0.7 | 0.17 | 3.6 | -12.85 | Upgrade
|
| EBT Excluding Unusual Items | -38.56 | -58.08 | -39.65 | -29.84 | 0.05 | -12.03 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.27 | -2.77 | -1.08 | -1.23 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.07 | - | 0.7 | - | 1.32 | - | Upgrade
|
| Asset Writedown | -7.18 | -15.49 | -110.36 | - | - | - | Upgrade
|
| Other Unusual Items | 0.42 | 7.31 | 4.75 | 3.58 | -1.58 | 10.06 | Upgrade
|
| Pretax Income | -49.39 | -66.26 | -144.83 | -29.03 | -1.28 | -3.2 | Upgrade
|
| Income Tax Expense | 0.05 | 0.17 | -5.02 | -20.12 | -3.26 | -1.54 | Upgrade
|
| Earnings From Continuing Operations | -49.45 | -66.43 | -139.81 | -8.91 | 1.98 | -1.66 | Upgrade
|
| Net Income | -46.03 | -66.43 | -139.81 | -8.91 | 1.98 | -1.66 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.16 | - | Upgrade
|
| Net Income to Common | -46.03 | -66.43 | -139.81 | -8.91 | 1.82 | -1.66 | Upgrade
|
| Shares Outstanding (Basic) | 46 | 44 | 42 | 39 | 27 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 46 | 44 | 42 | 39 | 27 | 19 | Upgrade
|
| Shares Change (YoY) | 5.56% | 2.91% | 10.33% | 41.01% | 40.32% | 19.71% | Upgrade
|
| EPS (Basic) | -1.01 | -1.52 | -3.29 | -0.23 | 0.07 | -0.09 | Upgrade
|
| EPS (Diluted) | -1.01 | -1.52 | -3.29 | -0.23 | -0.06 | -0.09 | Upgrade
|
| Free Cash Flow | 2.22 | -23.74 | -22.41 | -19.35 | -1.16 | -1.12 | Upgrade
|
| Free Cash Flow Per Share | 0.05 | -0.54 | -0.53 | -0.50 | -0.04 | -0.06 | Upgrade
|
| Gross Margin | 37.53% | 32.63% | 33.43% | 32.04% | 57.92% | 69.05% | Upgrade
|
| Operating Margin | -25.75% | -40.16% | -24.52% | -24.77% | -7.46% | 3.87% | Upgrade
|
| Profit Margin | -31.32% | -46.36% | -86.43% | -7.48% | 3.79% | -6.05% | Upgrade
|
| Free Cash Flow Margin | 1.51% | -16.57% | -13.85% | -16.24% | -2.42% | -4.08% | Upgrade
|
| EBITDA | -28.01 | -45.24 | -23.19 | -16.65 | 1.48 | 2.86 | Upgrade
|
| EBITDA Margin | -19.06% | -31.58% | -14.34% | -13.98% | 3.08% | 10.43% | Upgrade
|
| D&A For EBITDA | 9.84 | 12.3 | 16.47 | 12.87 | 5.07 | 1.8 | Upgrade
|
| EBIT | -37.85 | -57.53 | -39.66 | -29.52 | -3.59 | 1.06 | Upgrade
|
| EBIT Margin | -25.75% | -40.16% | -24.52% | -24.77% | -7.46% | 3.87% | Upgrade
|
| Revenue as Reported | 146.96 | 143.27 | 161.76 | 119.16 | 48.09 | 27.37 | Upgrade
|
| Advertising Expenses | - | 1.5 | 0.8 | 0.6 | 0.17 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.